Featured News
![](/sites/default/files/styles/4_3_medium/public/2024/07/03/aim-07-0456.jpg?itok=BZumbNaD)
AIM Blog
Recognizing AIM’s July Advocate of the Month: Molina Gonzales
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
![Molina forum](/sites/default/files/styles/4_3_small/public/2024/07/03/aim-07-0456.jpg?itok=LfMpcX6a)
AIM Blog
Recognizing AIM’s July Advocate of the Month: Molina Gonzales
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
![Doctor with patient](/sites/default/files/styles/4_3_small/public/2024/07/02/Doctor-going-through-a-report-with-senior-patient-155317574_6048x4032.jpeg?itok=EsS9YxaY)
Press Release
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™...
![Diverse group at capitol](/sites/default/files/styles/4_3_small/public/2024/05/14/aim-09-0565.jpg?itok=BdB0d3L8)
AIM Blog
Congress Can Take Action During Alzheimer’s & Brain Awareness Month
The lifetime risk for Alzheimer's at age 45 is 1 in 5 for women and 1 in 10 for men...
![ambulance](/sites/default/files/styles/4_3_small/public/2022/08/02/Ambulance.jpg?itok=X0fFcmBy)
AIM Blog
State Legislatures Take Action: Advancing Alzheimer’s Training for First Responders
Gloria Brown’s husband Arthur was diagnosed with Alzheimer’s in 2015. Two years later, while she was trying to get Arthur...
![Researcher with microscope](/sites/default/files/styles/4_3_small/public/2022/07/25/Researcher%20with%20Microscope.jpg?itok=4gB8Avz4)
Press Release
Alzheimer’s Association Welcomes FDA Advisory Committee Unanimous Vote of Efficacy of Donanemab for the Treatment of Early Alzheimer’s Disease
CHICAGO, June 10, 2024 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) advisory committee’s unanimous finding...
![John Mathis with Tony](/sites/default/files/styles/4_3_small/public/2024/06/04/aim-07-0652.jpg?itok=Oj-u7HAd)
AIM Blog
Recognizing AIM’s June Advocate of the Month: John Mathis
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...